Clinical Trial: DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
Study Status: Completed
Recruit Status: RECRUITING
Condition: Ductal Carcinoma in Situ
Study Type: INTERVENTIONAL
Official Title: DCIS: RECAST Trial -Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment: a Breast Cancer Prevention Pilot Study
Brief Summary:
The goal of this trial is to see if active surveillance monitoring and hormonal therapy in patients diagnosed with ductal cell carcinoma in situ (DCIS), an early stage of breast cancer, can be an effective management of the disease.Participants will be asked to receive standard of care hormonal therapy or an investigational treatment.Participants will be asked to return for evaluation with MRI at three months and six months.Depending on the evaluation participants will have the option to continue on the…
Read more